Understanding the influence of miasm in cases of chronic otitis media using - COMOT-15
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Reduction in COMOT-15 total score (ear symptoms, hearing function, mental health, and overall QoL) from baseline to end of treatment.
研究概览
简要总结
This study focuses on understanding the influence of miasm in cases of chronic otitis media using COMOT-15 as an assessment tool. Chronic otitis media is a highly prevalent condition that often leads to hearing impairment, recurrent discharges, and reduced quality of life. Conventional treatment frequently results in recurrence and antibiotic resistance. Homoeopathy, with its holistic and individualized prescriptions, takes into account the miasmatic background (Psora, Sycosis, Syphilis, Tubercular) which influences disease susceptibility, progression, and recurrence. This study aims to evaluate how different miasms affect the clinical outcome of chronic otitis media and whether individualized miasmatic treatment can improve quality of life, as measured by the COMOT-15 scale.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 15.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients above age of 14 years and all genders (including male, female and gender diverse individuals) are eligible for the study.
- •2.Patients with recurrent and chronic otitis media are eligible for the study.
- •3.Patients who are willing and are able to comply with the study protocol, including taking homoeopathic treatment, attending follow-up assessments are eligible for the study.
- •4.Patients who would give their written informed consent are eligible for the study.
排除标准
- •1.Patients having otitis media requiring only surgical intervention will be excluded.
- •2.Patients below age of 14 years will be excluded.
- •3.Patients with significant cognitive impairments will be excluded.
- •4.Patients who are unable or unwilling to comply with the study protocol, such as adhering to treatment regimen and attending follow-up visits will be excluded.
结局指标
主要结局
Reduction in COMOT-15 total score (ear symptoms, hearing function, mental health, and overall QoL) from baseline to end of treatment.
时间窗: Reduction in COMOT-15 total score (ear symptoms, hearing function, mental health, and overall QoL) from baseline to end of treatment.
次要结局
未报告次要终点
研究者
Dr Shilpaben Pareshbhai Vaghela
Anand Homeopathic Medical College and Research Institute, Anand.